Home >> HOLD >> CAP TODAY Webinar: Rapid Lung NGS is enabling clinicians and reducing biomarker testing costs

CAP TODAY Webinar: Rapid Lung NGS is enabling clinicians and reducing biomarker testing costs

image_pdfCreate PDF

CAP TODAY Webinar
Wednesday, May 24, 2023, 1:00 PM–2:00 PM ET

Register Now

Lauren Ritterhouse, MD, PhD
Associate Director, Center for Integrated Diagnostics
Massachusetts General Hospital
Assistant Professor, Pathology, Harvard Medical School

Ibiayi Dagogo-Jack, MD
Thoracis Oncologist, Massachusetts General Hospital
Assistant Professor of Medicine, Harvard Medical School

Why should you register now for this webinar?

Hear about experience from the Massachusetts General Hospital (MGH). Their Center for Integrated Diagnostics (CID) has consolidated legacy single gene testing system in to one workflow based on fast and automated next generation sequencing (NGS)—a rapid lung molecular testing program. This workflow allows for a turn around time (TAT) of 36-72 hours and provides clinicians with a consolidated biomarker report, whilst significantly reducing complexity, hands on time and costs in the lab.

CAP TODAY
X